# Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients

> **NCT04863053** · — · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 266 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **OTHER:** Blood samples will be taken to assess platelet function. There is no change in treatment.

## Key facts

- **NCT ID:** NCT04863053
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-02
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863053, "Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04863053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*